PAGIBAXIMAB

UNII:	23KB56UHN9
Formula:
Preferred Substance Name:	PAGIBAXIMAB

595566-61-3
A110
A-110
BSYX-A110
IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
PAGIBAXIMAB [INN]
PAGIBAXIMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PAGIBAXIMAB

Synonyms and Mappings

Resources